Shore Capital analysts initiated coverage on AstraZeneca PLC (NASDAQ:AZN) with a Buy rating on January 16, 2026.
AstraZeneca PLC operates in the Healthcare sector. The stock currently trades at $94.43 with a market capitalization of $279,947,333,682.


